NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 26, 2025 $2.06 +2.04% $2.11 V 97.69% 1
Sep 26, 2025 Bullish $2.11 X 1
Sep 22, 2025 $2.12 +3.55% $2.12 V 99.87% 6
Sep 22, 2025 $2.10 +2.22% $2.12 V 98.84% 2
Sep 22, 2025 Bullish $2.12 X 1
Sep 19, 2025 $2.27 +3.29% $2.05 X 89.15% 0
Sep 19, 2025 $2.25 +2.06% $2.05 X 90.47% 0
Sep 19, 2025 Bullish $2.05 X 0
Sep 17, 2025 $2.37 +3.23% $2.22 X 93.05% 0
Sep 17, 2025 $2.35 +2.02% $2.22 X 94.31% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE